Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 66 | 0 | 19 | 0 | 846,00 € | 883,50 € | 4,43 % |
| Biogen Inc. | 53 | 1 | 5 | 0 | 216,60 € | 292,88 € | 35,22 % |
| Vertex Pharmaceuticals Inc. | 52 | 2 | 6 | 0 | 437,65 € | 432,21 € | -1,24 % |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 11 | 0 | 982,60 € | 1.046,4 € | 6,49 % |
| Alnylam Pharmace. | 47 | 1 | 11 | 1 | 226,90 € | 251,80 € | 10,97 % |
| Johnson & Johnson | 38 | 1 | 6 | 0 | 136,42 € | 187,15 € | 37,19 % |
| AbbVie Inc. | 35 | 0 | 14 | 0 | 160,02 € | 175,98 € | 9,97 % |
| Cytokinetics Inc. | 34 | 1 | 4 | 0 | 48,40 € | 83,21 € | 71,91 % |
| Insmed Inc. | 34 | 0 | 15 | 0 | 62,50 € | 67,14 € | 7,42 % |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | 116,80 € | 125,34 € | 7,31 % |
| Neurocrine Bioscience | 33 | 0 | 3 | 0 | 128,55 € | 140,87 € | 9,58 % |
| Pfizer Inc. | 32 | 4 | 5 | 0 | 26,13 € | 40,66 € | 55,60 % |
| Intra-Cellular Therapies Inc. | 31 | 0 | 6 | 0 | 64,00 € | 83,92 € | 31,13 % |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | 15,30 € | 31,00 € | 102,70 % |
| Amgen Inc. | 28 | 0 | 4 | 0 | 291,80 € | 300,61 € | 3,02 % |